Patriot Financial Group Insurance Agency’s Tvardi Therapeutics TVRD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-322
Closed -$125K 491
2022
Q4
$125K Sell
322
-14
-4% -$5.32K 0.02% 406
2022
Q3
$113K Sell
336
-137
-29% -$49.6K 0.03% 380
2022
Q2
$156K Sell
473
-673
-59% -$236K 0.03% 439
2022
Q1
$501K Buy
1,146
+29
+3% +$11.9K 0.09% 234
2021
Q4
$490K Buy
1,117
+248
+29% +$125K 0.08% 248
2021
Q3
$483K Buy
+869
New +$436K 0.09% 240
2020
Q2
Sell
-6
Closed -$3K 1869
2020
Q1
$3K Hold
6
﹤0.01% 1257
2019
Q4
$3K Hold
6
﹤0.01% 1076
2019
Q3
$4K Hold
6
﹤0.01% 1001
2019
Q2
$4K Hold
6
﹤0.01% 1011
2019
Q1
$4K Sell
6
-8
-57% -$4.79K ﹤0.01% 916
2018
Q4
$7K Buy
14
+8
+133% +$5.16K ﹤0.01% 685
2018
Q3
$5K Hold
6
﹤0.01% 755
2018
Q2
$4K Sell
6
-33
-85% -$16.8K ﹤0.01% 511
2018
Q1
$17K Hold
39
0.01% 508
2017
Q4
$16K Hold
39
0.01% 503
2017
Q3
$19K Hold
39
0.02% 426
2017
Q2
$17K Buy
39
+6
+18% +$3.81K 0.02% 423
2017
Q1
$21K Hold
33
0.02% 349
2016
Q4
$14K Buy
+33
New +$10.6K 0.02% 414

Other funds holding TVRD

Patriot Financial Group Insurance Agency's TVRD Position: Q1 2023 in Review

Patriot Financial Group Insurance Agency sold out of Tvardi Therapeutics (TVRD) in Q1 2023, closing a stake of 322 shares — an estimated $125K sold.

Patriot Financial Group Insurance Agency first reported a position in TVRD in Q4 2016 and held it in 20 quarters. The position peaked at $501K in Q1 2022. 163 funds tracked by Wall St. Rank hold TVRD as of Q1 2023.

  • Patriot Financial Group Insurance Agency reported no remaining Tvardi Therapeutics position as of Q1 2023 after selling out during the quarter.
  • Patriot Financial Group Insurance Agency sold 322 Tvardi Therapeutics shares in Q1 2023, an estimated $125K.
  • Patriot Financial Group Insurance Agency first reported a position in Tvardi Therapeutics in Q4 2016 and held it in 20 quarters.
  • Patriot Financial Group Insurance Agency's Tvardi Therapeutics position peaked at $501K in Q1 2022.
  • 163 funds tracked by Wall St. Rank held Tvardi Therapeutics as of Q1 2023.

Based on Patriot Financial Group Insurance Agency's 13F filing for Q1 2023, filed 20 Apr 2023.